Quetiapine Fumarate Tablet
Product Images NDC 68071-3676

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 68071-3676). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3676 9)

Label for Quetiapine fumarate 25 mg tablets from NuCare Pharmaceuticals, Inc., NDC 68071-3676-09. The label states a quantity of 90 tablets, describes the tablet as round, biconvex, pink, debossed with 'LU' on one side and 'Y15' on the other. It also notes storage instructions, manufacturer details from Lupin Limited, India, and includes lot, serial, and expiration data boxes.*

FDA Label Image

Molecular Structure (E6dd3e1f 31d1 4d58 A717 D0bb4a4b8b6d 01)

Chemical structure diagram of quetiapine fumarate, showing the molecular composition and arrangement of the active ingredient quetiapine fumarate in the drug product labeled by NuCare Pharmaceuticals.*

FDA Label Image

Figure 1 (E6dd3e1f 31d1 4d58 A717 D0bb4a4b8b6d 02)

A Kaplan-Meier curve chart showing the proportion of patients with relapse over time in weeks. Two groups are compared: one labeled QTP+LI/VAL with a dashed line and the other PLA+LI/VAL with a solid line. The y-axis represents the percentage of patients with relapse, ranging from 0% to 100%, and the x-axis represents time up to 100 weeks.*

FDA Label Image

Figure 2 (E6dd3e1f 31d1 4d58 A717 D0bb4a4b8b6d 03)

A line graph showing the proportion of patients with relapse (%) over time in weeks. Two treatment groups are compared: QTP+LI/VAL (dashed line) and PLA+LI/VAL (solid line). The graph displays relapse rates increasing over 100 weeks, with PLA+LI/VAL having a higher proportion of relapses than QTP+LI/VAL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.